1. Home
  2. NVO vs LIN Comparison

NVO vs LIN Comparison

Compare NVO & LIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVO
  • LIN
  • Stock Information
  • Founded
  • NVO 1923
  • LIN 1879
  • Country
  • NVO Denmark
  • LIN United Kingdom
  • Employees
  • NVO N/A
  • LIN N/A
  • Industry
  • NVO Biotechnology: Biological Products (No Diagnostic Substances)
  • LIN Major Chemicals
  • Sector
  • NVO Health Care
  • LIN Industrials
  • Exchange
  • NVO Nasdaq
  • LIN Nasdaq
  • Market Cap
  • NVO 243.4B
  • LIN 217.0B
  • IPO Year
  • NVO N/A
  • LIN N/A
  • Fundamental
  • Price
  • NVO $48.46
  • LIN $418.23
  • Analyst Decision
  • NVO Buy
  • LIN Buy
  • Analyst Count
  • NVO 10
  • LIN 12
  • Target Price
  • NVO $80.40
  • LIN $508.70
  • AVG Volume (30 Days)
  • NVO 13.5M
  • LIN 2.5M
  • Earning Date
  • NVO 11-05-2025
  • LIN 10-31-2025
  • Dividend Yield
  • NVO 2.54%
  • LIN 1.44%
  • EPS Growth
  • NVO 10.06
  • LIN 13.37
  • EPS
  • NVO 3.67
  • LIN 14.94
  • Revenue
  • NVO $49,580,393,058.00
  • LIN $33,504,000,000.00
  • Revenue This Year
  • NVO $9.21
  • LIN $3.68
  • Revenue Next Year
  • NVO $5.64
  • LIN $5.54
  • P/E Ratio
  • NVO $13.22
  • LIN $27.99
  • Revenue Growth
  • NVO 16.64
  • LIN 1.45
  • 52 Week Low
  • NVO $45.05
  • LIN $408.65
  • 52 Week High
  • NVO $112.52
  • LIN $486.38
  • Technical
  • Relative Strength Index (RSI)
  • NVO 26.48
  • LIN 24.48
  • Support Level
  • NVO $48.49
  • LIN $409.00
  • Resistance Level
  • NVO $49.90
  • LIN $454.80
  • Average True Range (ATR)
  • NVO 1.21
  • LIN 6.89
  • MACD
  • NVO -0.58
  • LIN -2.73
  • Stochastic Oscillator
  • NVO 22.84
  • LIN 19.96

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About LIN Linde plc

Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2024.

Share on Social Networks: